Better Therapeutics (BTTX) Short Interest Ratio & Short Volume $0.0001 0.00 (0.00%) As of 06/25/2025 09:30 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Better Therapeutics Short Interest DataBetter Therapeutics (BTTX) has a short interest of 1,000 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 17,389 shares to cover all short positions.Current Short Interest1,000 sharesPrevious Short Interest1,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio0.0 Days to CoverLast Record DateJune 15, 2025Outstanding Shares49,862,000 sharesShort Percent of Float0.00%Today's Trading Volume750 sharesAverage Trading Volume17,389 sharesToday's Volume Vs. Average4% Short Selling Better Therapeutics? Sign up to receive the latest short interest report for Better Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBTTX Short Interest Over TimeBTTX Days to Cover Over TimeBTTX Percentage of Float Shorted Over Time Better Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20251,000 shares $0.00 No Change0.0%0 $0.00 5/31/20251,000 shares $0.10 No Change0.0%0.2 $0.00 5/15/20251,000 shares $0.20 No ChangeN/A0 $0.00 4/30/20251,000 shares $0.20 No ChangeN/A0.3 $0.00 4/15/20251,000 shares $0.10 No ChangeN/A0.1 $0.00 3/14/20251,000 shares $0.20 No ChangeN/A0.1 $0.00 2/28/20251,000 shares $0.20 No ChangeN/A0 $0.00 2/14/20251,000 shares $0.00 No ChangeN/A0 $0.00 1/31/20251,000 shares $0.00 No ChangeN/A5 $0.00 1/15/20251,000 shares $0.00 No ChangeN/A10 $0.00 Get the Latest News and Ratings for BTTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Better Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/15/20242,560,000 shares $114.18 thousand +20.2%8.3%0.4 $0.04 2/29/20242,130,000 shares $338.03 thousand +7.0%7.4%0.9 $0.16 2/15/20241,990,000 shares $405.96 thousand +107.1%6.9%1 $0.20 1/31/2024960,700 shares $181.76 thousand -29.9%3.4%0.5 $0.19 1/15/20241,370,000 shares $319.62 thousand +20.2%5.7%0.8 $0.23 12/31/20231,140,000 shares $222.30 thousand -38.0%4.5%0.4 $0.20 12/15/20231,840,000 shares $461.84 thousand -39.1%7.6%0.9 $0.25 11/30/20233,020,000 shares $591.62 thousand -2.3%13.0%1.5 $0.20 11/15/20233,090,000 shares $501.51 thousand +94.3%13.3%1.7 $0.16 10/31/20231,590,000 shares $227.05 thousand +117.5%8.3%1 $0.14 10/15/2023731,200 shares $229.45 thousand +201.8%4.4%0.5 $0.31 9/30/2023242,300 shares $88.68 thousand +6.7%1.2%0.3 $0.37 9/15/2023227,100 shares $113.66 thousand -14.9%1.1%0.3 $0.50 8/31/2023267,000 shares $165.57 thousand -6.7%1.3%0.3 $0.62 8/15/2023286,200 shares $189.21 thousand +79.0%1.4%0.3 $0.66 7/31/2023159,900 shares $119.37 thousand -68.1%1.0%0.2 $0.75 7/15/2023500,500 shares $425.53 thousand +752.6%4.9%0.6 $0.85 6/30/202358,700 shares $63.40 thousand +7.1%0.6%0.1 $1.08 6/15/202354,800 shares $53.70 thousand -38.3%0.5%0.3 $0.98 5/31/202388,800 shares $62.17 thousand -42.6%2.8%0.6 $0.70 5/15/2023154,600 shares $121.07 thousand +19.1%4.8%1.2 $0.78 4/30/2023129,800 shares $151.22 thousand -30.3%6.7%1.2 $1.17 4/15/2023186,200 shares $245.78 thousand +51.4%8.1%2.4 $1.32 3/31/2023123,000 shares $86.10 thousand +21.3%1.5%2.1 $0.70 3/15/2023101,400 shares $94.30 thousand +18.0%1.2%3.4 $0.93 2/28/202385,900 shares $103.08 thousand -21.5%1.1%3 $1.20 2/15/2023109,400 shares $132.38 thousand +2.7%1.4%3.9 $1.21 1/31/2023106,500 shares $145.91 thousand -30.7%1.4%3.3 $1.37 1/15/2023153,600 shares $211.97 thousand +6.6%2.0%4.1 $1.38 12/30/2022144,100 shares $159.23 thousand +17.4%1.9%3.6 $1.11Deploy the Income Machine for yourself this summer (Ad)Wall Street seems to be losing faith in stocks we thought were their favorites. Take Apple for example. Normally, new updates tend to rally their stock price. But here's what happened last week. The way I see it, Apple’s downtrend may continue as we inch closer to the thick of summer. And if I made a list of stocks to trade this summer, Apple most likely won't make that list. But rather than gamble on Apple stock... Buy shares outrightly... Or even keep an eye out for their next tech revolution before we act… A better idea might be to just zone in on the tickers and setups worth trading in the summer months.That's exactly why we're giving away FREE access to the all-new Income Machine. 12/15/2022122,800 shares $171.92 thousand +20.6%1.6%2.9 $1.40 11/30/2022101,800 shares $148.63 thousand +39.8%1.3%1.5 $1.46 11/15/202272,800 shares $104.83 thousand -38.2%1.0%0.9 $1.44 10/31/2022117,700 shares $182.44 thousand +22.6%1.5%0.9 $1.55 10/15/202296,000 shares $149.76 thousand +15.3%1.3%0.1 $1.56 9/30/202283,300 shares $146.61 thousand -15.1%1.1%0.1 $1.76 9/15/202298,100 shares $201.11 thousand -58.4%1.3%0.1 $2.05 8/31/2022235,600 shares $402.88 thousand +161.5%3.0%0.2 $1.71 8/15/202290,100 shares $163.08 thousand +55.3%1.2%0 $1.81 7/31/202258,000 shares $128.76 thousand -74.3%0.8%0 $2.22 7/15/2022225,400 shares $376.42 thousand -35.8%2.9%0 $1.67 6/30/2022351,100 shares $547.72 thousand +2.2%4.6%0.1 $1.56 6/15/2022343,700 shares $501.80 thousand -66.0%4.5%0.1 $1.46 5/31/20221,010,000 shares $1.83 million -46.0%13.0%0.2 $1.81 5/15/20221,870,000 shares $3.25 million +1,885.1%24.0%0.3 $1.74 4/30/202294,200 shares $85.91 thousand +73.8%1.2%0 $0.91 4/15/202254,200 shares $76.42 thousand +54.9%0.7%0.3 $1.41 3/31/202235,000 shares $69.30 thousand -82.4%0.5%0.3 $1.98 3/15/2022198,500 shares $619.32 thousand +0.5%2.5%1.8 $3.12 2/28/2022197,500 shares $564.85 thousand -12.4%2.5%1.8 $2.86 2/15/2022225,400 shares $852.01 thousand +6.0%2.9%0.6 $3.78 1/31/2022212,700 shares $821.02 thousand -1.1%2.4%0.5 $3.86 1/15/2022215,100 shares $989.46 thousand -19.5%2.5%0.1 $4.60 12/31/2021267,200 shares $1.24 million No Change3.1%0.1 $4.65 BTTX Short Interest - Frequently Asked Questions What is Better Therapeutics' current short interest? Short interest is the volume of Better Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 1,000 shares of BTTX short. 0.00% of Better Therapeutics' shares are currently sold short. Learn More on Better Therapeutics' current short interest. What is a good short interest percentage for Better Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Better Therapeutics' floating shares are currently sold short. How does Better Therapeutics' short interest compare to its competitors? 0.00% of Better Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Better Therapeutics: UpHealth, Inc. (0.07%), Fresenius Medical Care AG & Co. KGaA (0.29%), Natera, Inc. (4.93%), Hims & Hers Health, Inc. (33.86%), Guardant Health, Inc. (7.60%), Option Care Health, Inc. (3.57%), RadNet, Inc. (9.62%), BrightSpring Health Services, Inc. (14.46%), Sotera Health Company (8.50%), Surgery Partners, Inc. (12.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Better Therapeutics stock? Short selling BTTX is an investing strategy that aims to generate trading profit from Better Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Better Therapeutics? A short squeeze for Better Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BTTX, which in turn drives the price of the stock up even further. How often is Better Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BTTX, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies UpHealth Short Interest American Oncology Network Short Interest Fresenius Medical Care AG & Co. KGaA Short Interest LifeMD Short Interest P3 Health Partners Short Interest Talkspace Short Interest Oncology Institute Short Interest Natera Short Interest Hims & Hers Health Short Interest Guardant Health Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BTTX) was last updated on 6/27/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BTTX Stock Free BTTX Stock Alerts